Clinical and Pathological Characteristics of Stage IV SMARCA4-Deficient Lung Cancer and the Efficacy of Immune Checkpoint Inhibitors

Clinical Oncology 2026

View at publisher
Authors: Jintao Ma, Minying Deng, Xiaohong Xu, Yingyong Hou, Jian He
DOI: 10.1016/j.clon.2026.104093
Cited by: 3
References: 24

Fields of Study & Subjects

Chromatin Remodeling and Cancer Metastasis and carcinoma case studies Histone Deacetylase Inhibitors Research

Publication details

Journal / source
Clinical Oncology
Publisher
Elsevier BV
Volume
52
Pages
104093–104093
Publication date
20 February 2026
Language
EN